Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Passau

8 clinical trials in Passau, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Passau at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Passau

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BLEXIMENIB
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Blinatumomab
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enasidenib Mesilate
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Passau

What the registry says about research in the country

01 Hematologic Malignancies

Leading research focusing on Acute Myeloid Leukemia (AML) and various genetic mutations, evaluating innovative treatment combinations and targeted therapies.

  • AML with genetic mutations
  • Myelodysplastic Syndrome
  • IDH1/IDH2 mutations

Studies comparing different chemotherapy approaches and investigating novel therapeutic combinations for improved patient outcomes.

02 Lymphoid Disorders

Clinical investigations targeting Philadelphia-Chromosome positive ALL and Marginal Zone Lymphoma, exploring innovative treatment strategies.

  • Acute Lymphoblastic Leukemia
  • MALT Lymphoma
  • Treatment Response Assessment

Evaluating targeted therapies and immunotherapy approaches in combination with conventional treatments.

03 Solid Tumors

Research initiatives examining treatments for metastatic colorectal cancer and HER2-negative breast cancer, focusing on post-treatment strategies.

  • Post-resection therapy
  • High-risk breast cancer
  • Novel therapeutic approaches

Investigating innovative treatment sequences and comparing effectiveness of various therapeutic options.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.